Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets-Reference-Cited by-同舟云学术

Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets

Published:2020-04 Issue:S1 Volume:22 Page:16-31
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Barrera‐Chimal Jonatan¹,Jaisser Frédéric²³⁴^ORCID

Affiliation:

1. Laboratorio de Fisiología Cardiovascular y Trasplante Renal, Unidad de Investigación en Medicina Traslacional, Instituto de Investigaciones BiomédicasUniversidad Nacional Autónoma de México and Instituto Nacional de Cardiología Ignacio Chávez Mexico City Mexico

2. INSERM, UMRS 1138, Centre de Recherche des CordeliersSorbonne University, Paris Descartes University Paris France

3. INSERM U1116, Clinical Investigation CentreLorraine University Vandoeuvre‐lès‐Nancy France

4. INI‐CRCT (Cardiovascular and Renal Clinical Trialists) F‐CRIN Network Nancy France

Funder

Agence Nationale de la Recherche

Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México

European Cooperation in Science and Technology

Fondation pour la Recherche Médicale

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13969

Reference189 articles.

1. Diagnosis and Management of Type 2 Diabetic Kidney Disease

2. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease

3. Diabetic kidney disease

4. Genetic and Epigenetic Risk Factors for Diabetic Kidney Disease

5. Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND)

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential of Anti-Inflammatory DC Immunotherapy in Improving Proteinuria in Type 2 Diabetes Mellitus;Vaccines;2024-08-27

2. Piperazine ferulate inhibits diabetic nephropathy by suppressing AGE/RAGE-mediated inflammatory signaling in rats and podocytes;Frontiers in Pharmacology;2024-08-01

3. The causal role between circulating immune cells and diabetic nephropathy: a bidirectional Mendelian randomization with mediating insights;Diabetology & Metabolic Syndrome;2024-07-16

4. Comparative efficacy and safety of SGLT2is and ns-MRAs in patients with diabetic kidney disease: a systematic review and network meta-analysis;Frontiers in Endocrinology;2024-07-04

5. Patient Characteristics and Outcomes of Hospitalized Chronic Kidney Disease Patients with and without Type 2 Diabetes Mellitus: Observations from the German Claims Data-Based Cohort of the CaReMe-CKD Multinational Study;Clinical Epidemiology;2024-07